Imricor Medical Systems, Inc.
Imricor Medical Systems, Inc.
Your view on IMR.AX
Overview
What the company does, where it operates, and who runs it.
About Imricor Medical Systems, Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Steven Wedan
- Headquarters
- 400 Gateway Boulevard, Burnsville, MN, US
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Steven Wedan
- Headquarters
- 400 Gateway Boulevard, Burnsville, MN, US
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.
0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator.
It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Imricor Medical Systems, Inc.. Starting points for Imricor Medical Systems, Inc.: EPS -AUD 0.12, beta 0.46 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Imricor Medical Systems, Inc.. Imricor Medical Systems, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Imricor Medical Systems, Inc.. Trailing twelve-month EPS for Imricor Medical Systems, Inc. stands at -AUD 0.12. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrMar 2024 | Next QtrJun 2024 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $0.00 | $0.00 | −$0.09 | −$0.07 |
| Low estimate | $0.00 | $0.00 | −$0.12 | −$0.10 |
| High estimate | $0.00 | $0.00 | −$0.07 | −$0.04 |
| No. of analysts | 0 | 0 | 3 | 3 |
| Year-ago EPS | — | — | −$0.091 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrMar 2024 | Next QtrJun 2024 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $596997.00 | $5.12M | $1.57M | $9.33M |
| Low estimate | $596997.00 | $5.12M | $433306.00 | $8.02M |
| High estimate | $596997.00 | $5.12M | $2.46M | $11.47M |
| No. of analysts | 1 | 1 | 3 | 4 |
| Year-ago revenue | — | — | $302502.00 | — |
| Growth | — | — | +417.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Imricor Medical Systems, Inc.. Imricor Medical Systems, Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ACAISafeplus International Holdings Limited | Healthcare | OTC | $477 | ||
| ADLIAmerican Medical Technologies Inc. | Healthcare | OTC | $1,031 | ||
| AIMVAI Maverick Intel, Inc. | Healthcare | OTC | $3.0M | ||
| ALCAlcon Inc. | Healthcare | NYSE | $36.2B | ||
| ANIKAnika Therapeutics, Inc. | Healthcare | NASDAQ | $182.4M | ||
| APYXApyx Medical Corporation | Healthcare | NASDAQ | $104.9M | ||
| ASFXAmerican Scientific Resources, Incorporated | Healthcare | OTC | $7,001 | ||
| AVTIAvitar, Inc. | Healthcare | OTC | $1,382 | ||
| BEATHeartBeam, Inc. | Healthcare | NASDAQ | $21.6M | ||
| BEATWHeartBeam, Inc. | Healthcare | NASDAQ | $6.6M | ||
| BIELBioElectronics Corporation | Healthcare | OTC | $7.2M | ||
| BMGPBiomagnetics Diagnostics Corp. | Healthcare | OTC | $1,265 | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VAS.AXVanguard Australian Shares Index ETF | $27.0B in assets | 0.02% | |
| ISO.AXiShares S&P/ASX Small Ordinaries ETF | $120M in assets | 0.18% | |
| SSO.AXState Street SPDR S&P/ASX Small Ordinaries ETF | $24M in assets | 0.19% | |
Largest holders first, then the funds most concentrated in IMR.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Imricor Medical Systems, Inc.. Coverage tracks Imricor Medical Systems, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Imricor Medical Systems, Inc.